Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Primary redox qHTS assay for identification of artifact compounds.
Assay data:19 Active, 16 Activity ≤ 1 µM, 5098 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Depositor
Primary Nanoluciferase (NLuc) qHTS assay for identification of artifact compounds.
Assay data:37 Active, 2 Activity ≤ 1 µM, 5098 Tested
Primary firefly luciferase (FLuc) qHTS assay for identification of artifact compounds.
Assay data:75 Active, 14 Activity ≤ 1 µM, 5098 Tested
Primary qHTS Assay for Inhibitors of Recombinant Selenoprotein Glutathione Peroxidase 4 (GPX4)
Assay data:258 Active, 16 Activity ≤ 1 µM, 11046 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Primary qHTS Assay for Inhibitors of Recombinant Selenoprotein Glutathione Peroxidase 1 (GPX1)
Assay data:186 Active, 9 Activity ≤ 1 µM, 11353 Tested
Antitumor activity against human MV4-11 cells xenografted in BALB/c mouse assessed as tumor growth inhibition at 2 to 4 mg/kg, po administered for 24 days
Assay data:2 Tested
SummaryPubMed Citation
Drug screen in RCMB18 medulloblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:10 Active, 378 Tested
SummaryCompounds, ActiveRelated BioAssays by Depositor
Drug screen in BT084 (ICGC_MB145) medulloblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:9 Active, 378 Tested
Drug screen in Human astrocytes as non-malignant controls to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:23 Active, 378 Tested
Drug screen in UWB1.289_BRCA1 ovarian carcinoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:26 Active, 378 Tested
Drug screen in MDA-MB-436 breast carcinoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:4 Active, 378 Tested
Drug screen in LFS_MB_2R medulloblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:11 Active, 378 Tested
Drug screen in UWB1.289 ovarian carcinoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:14 Active, 378 Tested
Drug screen in CRL2098 osteosarcoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:20 Active, 378 Tested
Drug screen in HTB85 osteosarcoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:38 Active, 378 Tested
Drug screen in LFS_MB_1R medulloblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:21 Active, 378 Tested
Drug screen in ICB984 medulloblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:378 Tested
SummaryRelated BioAssays by Depositor
Drug screen in HDN33 neuroblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:32 Active, 378 Tested
Drug screen in LFS_MB_P medulloblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Primary qHTS assay for inhibitors of Glutamate pyruvate transaminase 2 (GPT2)
Assay data:249 Active, 449 Activity ≤ 1 µM, 100803 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on